Micro Imaging Technology - HOT!?
Seite 1 von 4 Neuester Beitrag: 20.09.11 16:24 | ||||
Eröffnet am: | 27.07.11 11:07 | von: voidindexxx | Anzahl Beiträge: | 83 |
Neuester Beitrag: | 20.09.11 16:24 | von: der-gerechte | Leser gesamt: | 7.011 |
Forum: | Hot-Stocks | Leser heute: | 8 | |
Bewertet mit: | ||||
Seite: < | 2 | 3 | 4 > |
Bin gestern auf diesen Stock aufmerksam geworden - mit über 100 Mio. trades in den USA ist hier eindeutig was im Gange und die Aktie wird seit Tagen in allen möglichen Foren diskutiert u.a. im IHUB - gestern lange Zeit auf Platz 1 bei den Breakout-Boards - Grund dafür gibts auch:
------
Micro Imaging Technology and EPIC Corporation Announce a Significant Equity Alliance
(26.07.2011)
Quelle: http://ih.advfn.com/p.php?pid=nmona&article=48570323
------
Was meint Ihr zu dem Teil? Zock wert?!
Mehr Infos zum Unternehmen: http://www.micro-imaging.com/
Mit nur etwas mehr als 101 Mio im float und den gestrigen Umsätzen, sollte hier doch eigentlich was zu holen sein! :)
SHARE STRUCTURE AS OF LAST 10-Q
A/S 500 Mill
Outstanding Shares: 213,791,418
Total Float: 101,620,622
Insiders on roughly 50% of the float
über dem gestrigen schlusskurs und das ask steht bei 0,004 - in amerika wird auch um diese uhrzeit schon/noch diskutiert!
http://investorshub.advfn.com/boards/board.aspx?board_id=13754
ask steigt, bid fällt - wird versucht zu drücken... die meisten meinen, dass ein einstieg unter 0,004 kaum mehr möglich sein wird... bid steht allerdings aktuell auf 0,0024 ... ask bei 0,0046 !
bin gespannt! :)
kurz vor börsenschluss wurden 16 Mio aktien gekauft, die als unterstützung bei 0,0030 dienen und auf mehr hoffen lassen! :)
aktuell: bid 0,0033 / ask 0,0040
ich will meinungen! :) und wenn ihr meint, dass das teil mist ist, will ich das hören - geht ja schließlich auch um mein geld! ;)
scheinen gleich mal zu fallen, geht so weiter, wie es gestern aufgehört hat - große umsätze
bid bei 0,0039
21 % plus
ask steht gleich mal bei 0,0044
wer auch immer mir da sternchen gibt, soll die lieber dem thread geben ;)
EPIC Corporation (PINKSHEETS: EPOR) (the "Company"), announced that it has entered into a significant long-term equity alliance with Micro Imaging Technology, Inc. Under the terms of the signed Memorandum of Understanding, EPIC has committed to purchasing a substantial equity position in MIT and as a healthcare products and services company, it will receive the benefits of MIT's revolutionary technology.
"EPIC is fortunate to become a part of Micro Imaging Technology," said Ronald Tucker, CEO of EPIC. "We believe that Micro Imaging is undervalued. The Company's balance sheet fails to reflect the value of the commercialized device for identifying bacteria and the 20 or more libraries that can be used to identify other bacterium, including MRSA."
ABOUT MICRO IDENTIFICATION TECHNOLOGIES:
MIT is a California-based public company that has developed and patented a Rapid Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process. The System identifies bacteria in minutes and at a significant per test cost savings when compared to any conventional methods. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process requires only clean water and a sample of the unknown bacteria.
MIT previously completed an extensive evaluation by the AOAC RI Institute which included rigorous independent testing and thorough reviews by its expert examiners, including the U.S. Department of Agriculture.
MIT has also demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. The System can currently identify 23 species of bacteria and its capabilities are easily expanded. The identification process has been verified by North American Science Associates, Inc. (NAMSA), an independent and internationally recognized microbiological testing laboratory. See www.micro-imaging.com.
About EPIC
Our business plan is to enter into agreements with companies like Micro Imaging who are developing technology to provide people with better healthcare. The essence of these agreements is to provide the companies with funding for regulatory approval, if necessary, product commercialization, product procurement, marketing and distribution. See www.epiccor.com.
CONTACT:
Ronald Tucker
CEO
Email:
Telephone: (760) 771-0036
Micro Imaging Technology, Inc. (OTCBB: MMTC) (OTCQB: MMTC) announced that it has entered into a significant long-term equity alliance with EPIC Corporation (OTC: EPOR). Under the terms of the signed Memorandum of Understanding, EPIC has committed to purchasing a substantial equity position in MIT and, as a health care products supplier, will receive the benefits of MIT's revolutionary technology.
MIT has developed and patented a Microbial Identification System that revolutionizes the pathogenic bacteria identification process and can annually save thousands of lives and tens of millions in health care costs. The MIT 1000 System is believed to be the fastest and most inexpensive bacterial identification system available; identifying bacterial strains in less than five minutes, at a cost of less than 10 cents per test and extremely easy to operate. The MIT 1000 System has been certified by the AOAC Research Institute (AOAC RI) as a test method for Listeria, one of the three pathogens that are responsible for most of the worldwide food contaminations. The Company is in the process of preparing the MIT 1000 System for further certifications for the identification of both Salmonella and E. coli later this year. This will give the MIT 1000 System the certified ability to identify all "three of the major infectious pathogens" within five minutes and with a single test.
"EPIC is fortunate to become a part of Micro Imaging Technology," said Ronald Tucker, CEO of EPIC. "We believe that Micro Imaging is undervalued. The Company's balance sheet fails to reflect the value of the commercialized device for identifying bacteria and the 20 or more libraries that can be used to identify other bacterium, including MRSA."
"EPIC's business plan is to enter into agreements with companies like Micro Imaging, who are developing technologies to provide people with better healthcare. The essence of these agreements is to provide the companies with funding for regulatory approval, product commercialization, product procurement, marketing and distribution," stated Mr. Tucker.
Replying, Michael Brennan, MIT's Chairman, said, "The agreement with EPIC will provide us with needed funding now that we have entered our production stage and provides a partner that is very familiar with the healthcare industry. This will enable MIT to approach other markets in healthcare in addition to the $5 billion food safety segment."
ABOUT MICRO IDENTIFICATION TECHNOLOGIES:
MIT is a California-based public company that has developed and patented a Rapid Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of health care costs. The System identifies bacteria in minutes, not days, and at a significant per test cost savings when compared to any conventional method. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process is totally GREEN requiring only clean water and a sample of the unknown bacteria. Revenues for all rapid testing methods exceed $5 billion annually -- with food safety accounting for over $3.5 billion, which is expected to surpass $4.7 billion by 2015 according to BCC Research. In addition, the recently passed "New" U.S. Food Safety Bill is expected to further accelerate the current CAGR growth rate of 6.6%.
MIT previously completed an extensive evaluation by the AOAC RI Institute which included rigorous independent testing and thorough reviews by its expert examiners, including the U.S. Department of Agriculture. The AOAC RI Report is available from the Company. www.aoac.org
MIT has also demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. MIT recently performed over 300 tests for the identification of these contaminants and scored 95% accuracy. The System can currently identify 23 species of bacteria and its capabilities are easily expanded. The identification process has been verified by North American Science Associates, Inc. (NAMSA), an independent and internationally recognized microbiological testing laboratory. The NAMSA Test Report is available from the Company and, in MIT's opinion, demonstrates the accuracy, speed and cost effectiveness of the System over conventional processes. www.namsa.com
This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission. www.sec.gov, Referencing MMTC.
CONTACT:
Michael Brennan
Chairman
Email: Email Contact
Web Site: www.micro-imaging.com
Telephone: (805) 557-0614
bid steigt.. wenn die 0,004 nachhaltig gebrochen sind, ists ganz dünn... sollte dann eigentlich nur noch eine richtung kennen... wenn man die news genauer bedenkt und versteht, ist das ne riesensache die da grad passiert oder meine englischkenntnisse lassen zu wünschen übrig!
MPID | Bid Price | Size | Date/Time |
---|---|---|---|
VERT | 0.0038 | 25000 | 12:11 |
NITE | 0.0036 | 2070000 | 12:48 |
ETMM | 0.0036 | 38439 | 12:03 |
AUTO | 0.0032 | 300000 | 12:50 |
UBSS | 0.0011 | 500000 | 12:42 |
VFIN | 0.001 | 5000 | 11/09 |
HDSN | 0.0008 | 5000 | 07/19 |
CSTI | 0.0001 | 5000 | 06/30 |
PERT | 0.0001 | 5000 | 10:37 |
MPID | Ask Price | Size | Date/Time |
---|---|---|---|
PERT | 0.0039 | 200000 | 12:54 |
AUTO | 0.004 | 77000 | 12:50 |
ETMM | 0.0041 | 500000 | 12:36 |
NITE | 0.0042 | 4138655 | 12:32 |
UBSS | 0.0046 | 50000 | 12:42 |
HDSN | 0.05 | 5000 | 12/20 |
VFIN | 0.10 | 5000 | 12/14 |
CSTI | 0.2533 | 5000 | 06/30 |
VERT | 0.51 | 10000 | 07/26 |
http://www.otcmarkets.com/stock/MMTC/quote
Aug. 8, 2011, 9:01 a.m. EDT
EPIC and Micro Imaging Technology Enter Strategic Alliance and EPIC Declares
AUSTIN, TX, Aug 08, 2011 (MARKETWIRE via COMTEX) -- EPIC Corporation (pinksheets:EPOR) (the "Company") announced an equity investment in Micro Imaging
"Our equity investment in MIT is in a convertible promissory note," said Ronald Tucker, CEO of EPIC. "The note, after six months from the issuance date, is convertible into MIT's common stock based on its fair market value as of the time of conversion."
The Company has formed EPIC Healthcare, Ltd., a single member limited liability company, and is to be the Master Distribution company for the MIT products.
"Under the distribution agreement, we are preparing a program to license MIT's hardware and software libraries for detecting over 20 different types of bacterium," said Mr. Tucker. "We believe that within the next year we will sell close to 30 licenses generating approximately $900,000 in one time license fees. In addition, we will receive a monthly maintenance fee, and a fee per test."
The Company's Board of
MIT is a California-based public company that has developed and patented a Rapid Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process. This system can detect and identify, within minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. The process has been verified by North American Science Associates, Inc. (NAMSA), and has been through an extensive evaluation by the AOAC RI Institute.
EPIC's business plan is to enter into agreements with companies like MIT who are developing technology to provide people with better healthcare. See www.epiccor.com .
CONTACT:
Ronald Tucker
CEO
Email: Email Contact
Telephone: (760) 771-0036
schaut euch das teil doch mal an, die news, die story dahinter.
das ist es was MMTC macht:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65995315
und das ist es was sie u.a. anbieten:
"The MIT 1000 features 35 photo detectors that surround the sample vial and collect light scattering intensities that are generated when a cell intersects the laser beam. The scattering values collected by the detectors are statistically analyzed by MIT's proprietary software that contains an extensive database of values for each bacteria seen by the photo detectors. Identification occurs when 10-50 organisms are analyzed, and typically takes less than 10 minutes."
es ist bereits die rede davon, dass der MIT 1000 in sachen bakterien-forschung/analyse/etc neue maßstäbe setzt und revolutionär ist... ich denke, dass nach den 100 % von gestern, heute erstmal gewinnmitnahmen kommen werden und es durchaus sein kann, dass man hier nochmal billig einsteigen kann. nach den letzten 2 wochen und dem enorm gestiegenen interesse, denk ich, dass hier nach oben hin jede menge platz ist!
in der ersten halben stunde! nach leichtem minus gehts wieder aufwärts, hier steckt wirklich dynamit drinnen - alles möglich bei dem volumen - vielleicht fallen sogar die 0,015 oder 0,02 - mal sehen :)
ich kann die gar nicht ordern über sbroker :-/
okisch voidindexxx
pinksheets nicht handeln? muss bei manchen brokern extra angefragt werden... auch bei den meisten banken, meine tradet viele pennys nur via telefonbanking